Exicure, Inc. (XCUR)
NASDAQ · Healthcare
Exicure, Inc. Revenue 2016–2025
Exicure, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Exicure, Inc. revenue for the quarter ending March 31, 2026 was 0.
- Exicure, Inc. revenue for the twelve months ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Exicure, Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Exicure, Inc. annual revenue for 2024 was 500000.
- Exicure, Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Exicure, Inc. annual revenue for 2022 was 28.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Exicure, Inc. (XCUR) — Frequently Asked Questions
Exicure, Inc. (XCUR) is a publicly traded US company. It has a market capitalization of $17M. Explore XCUR's stock price, financial statements, earnings history, margins and key ratios below.
What is Exicure, Inc.'s market cap?
Exicure, Inc. (XCUR) has a market capitalization of $17M.
What is the XCUR stock price?
XCUR trades at $2.76 (-3.16% on the day).
Is XCUR profitable?
In fiscal 2025, Exicure, Inc. reported net income of -$5M.